InvestorsHub Logo
Followers 91
Posts 28855
Boards Moderated 2
Alias Born 04/19/2013

Re: no2koolaid post# 351855

Friday, 02/19/2021 12:44:17 PM

Friday, February 19, 2021 12:44:17 PM

Post# of 401090
Contradictory and NONSENSE!!

Am I clear about the bottom line? That Elite shareholders would NOT have the same value based on a p/s? It is about a third party valuation and there is always a premium paid and in pharma that premium is higher than in other industries. That is precisely why we want Nasrat and Elite to take their time...right now the Elite "cake" is only half-baked!



Where did this TOTAL BS come from?

By definition then, an acquiree always has a price per share LOWER than the valuation study concludes? How else can there always be a premium paid to the P/S then???

BULLSHIT PERSONIFIED!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News